10jili net
Canada's Irving Tissue plans a $600 million factory expansion in Georgia, hiring 100 more workers
Published 4:49 pm Friday, November 22, 2024 By Data Skrive The Notre Dame Fighting Irish versus the USC Trojans is one of three games on Saturday’s college basketball schedule that includes a ranked team in action. Watch women’s college basketball, other live sports and more on Fubo. What is Fubo? Fubo is a streaming service that gives you access to your favorite live sports and shows on demand. Use our link to sign up for a free trial. Catch tons of live women’s college basketball , plus original programming, with ESPN+ or the Disney Bundle.
MARA Holdings, Inc. Completes $850 Million Offering of Zero-Coupon Convertible Senior Notes due 2031
Tech Triumph! Here’s Why HPE is SurgingNone
Analysis included 230 studies—a mix of randomized, prospective, and database research SUNNYVALE, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:ISRG) The peer-reviewed Annals of Surgery published a meta-analysis of 30-day surgical outcomes across seven oncological surgical procedures , comparing robotic, laparoscopic, and open surgical approaches. The study covered a 12-year timeframe and analyzed 230 studies from 22 countries: 34 randomized controlled trials, 74 prospective studies, and 122 database reviews. Each surgical approach represented more than a million procedures. The meta-analysis, conducted by scientists from Intuitive and Massachusetts General Hospital, demonstrated multiple benefits for robotic surgery using Intuitive’s da Vinci system as compared to laparoscopy and open surgery. “Robotic surgery with da Vinci showed fewer conversions, less blood loss, fewer blood transfusions, fewer readmissions and reoperations, and a shorter length of stay after 30 days,” said Intuitive Executive Vice President and Chief Medical Officer Myriam Curet, MD. “The editors at the Annals of Surgery thoroughly scrutinized and peer-reviewed this study prior to acceptance,” said Curet. “The quality of scientific data we are seeing after decades of robotic surgery underscores the value that the da Vinci robotic approach continues to have for improved surgical care.” Notable study results included: Da Vinci robotic cases were 56 percent less likely to convert to open surgery versus laparoscopy. Da Vinci robotic cases saw less blood loss versus open, comparable blood loss with laparoscopy. Da Vinci robotic cases were 21 percent less likely to require blood transfusions versus laparoscopy and 75 percent versus open. Da Vinci cases were 10 percent less likely to experience 30-day postop complications versus laparoscopy; 44 percent versus open. Da Vinci cases saw a half-day savings in hospital stay compared to laparoscopy and 1.9 days compared to open. Operative time for da Vinci cases was 17.7 minutes longer than laparoscopy and 40.9 minutes longer than open. “The data presented in our study describes the value of robotics in both the controlled clinical setting of randomized controlled trials and in the ‘real-clinical-world’ of population-based studies,” said Rocco Ricciardi, MD, MPH, lead study author and chief of colon and rectal surgery at the Massachusetts General Hospital. “Ultimately, demonstrating population-based gains with robotics allows us to determine value of robotic procedures for the average person who might need surgery.” Traditional minimally invasive surgery offers many benefits but presents several technical limitations—notably lower quality vision and depth perception, camera instability, limited range of motion and dexterity due to the straight and rigid hand-held instruments, and it can take a severe physical toll on the surgeon. Intuitive technology introduced in the da Vinci surgical system has helped surgeons overcome many of those technological limitations via advanced 3DHD vision, wristed instrumentation, and greater precision, especially in deep, limited, or narrow areas of the body such as the chest, abdomen, and pelvis. There have been numerous studies comparing perioperative outcomes between robotic, laparoscopic, and open surgery but they have focused on individual procedures, which result in procedure-specific evaluations. Intuitive’s study in the Annals of Surgery looked at randomized controlled trials, prospective cohort, and database studies published within the last 12 years, and it shows multiple benefits for robotic surgery using the da Vinci system compared to laparoscopic and open surgery, which may be useful to decision makers who are considering the use of robotics in a multi-specialty setting. The study scope focused on 30-day outcomes specific to oncology procedures that often require deep and narrow surgical access. It did not review oncologic outcomes. About Intuitive Intuitive (NASDAQ:ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most. About da Vinci Surgical Systems There are several models of the da Vinci Surgical System. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body. For more information, please visit the company’s website at www.intuitive.com . Important Safety Information Serious complications may occur in any surgery, including da Vinci surgery, up to and including death. Serious risks include, but are not limited to, injury to tissues and organs and conversion to other surgical techniques which could result in a longer operative time and/or increased complications. For summary of the risks associated with surgery refer to www.intuitive.com/safety. For product intended use and/or indications for use, risks, cautions, and warnings and full prescribing information, refer to the associated user manual(s) or visit https://manuals.intuitivesurgical.com/market. Individual outcomes may depend on a number of factors—including but not limited to—patient characteristics, disease characteristics, and/or surgeon experience. Contact Information Peper Long, Intuitive 202-997-7373 peper.long@intusurg.comPolice are investigating “dozens” of people at the Post Office and Fujitsu over the Horizon scandal , a senior police officer has said. Met Commander Stephen Clayman said investigators had identified "dozens" of people of interest over the scandal, which saw hundreds of sub-postmasters wrongly convicted for theft and fraud due to the faulty Horizon software. However, no charging decisions have been made until a public inquiry into the scandal publishes its final report. One hundred police officers from across the UK are now working on the investigation, which is focusing on potential crimes of perjury and perverting the court of justice. Police have said the inquiry is "unprecedented" in size, with potentially more than 3,000 victims and evidence currently including more than 1.5 million documents that have to be reviewed. Commander Clayman said: "The scale of the task ahead is unprecedented and I am confident we have an excellent team in place, with the support of cutting-edge technology to strengthen our search for information and evidence in amongst the 1.5 million-plus documents obtained and which will grow. "I do know that if you take into account Post Office criminal and private prosecutions, civil claims and contract withdrawals, there are potentially thousands of victims who we are working hard to identify and build our database so that we can ensure we reach as many affected individuals as possible. "I cannot make promises that this will be a fast process. An investigation of this size must continue to be undertaken meticulously and methodically and will take time. "However, I speak on behalf of our whole team when I say we will approach it with independence, precision and integrity." Closing statements will be heard in the inquiry on December 16 and 17, but no firm timetable has yet been set for its final report. This means any potential trials may not take place until 2027. Last month the Met said four suspects had so far been identified in the investigation , and that the number was expected to rise. Three have been interviewed under caution so far since 2021, with the most recent in September this year, and more are expected to be questioned next year. Investigators are looking at "a significant number of people" from the Post Office, Fujitsu and in the legal profession, police said in a briefing for journalists on Tuesday. More than 900 sub postmasters were prosecuted between 1999 and 2015 after faulty Horizon accounting software made it look as though money was missing from their accounts. Hundreds are still awaiting compensation despite the previous government saying that those who have had convictions quashed are eligible for £600,000 payouts. The scandal is one of the most widespread miscarriages of justice in British legal history. A Post Office spokesperson said: "Post Office has co-operated fully and openly with the Metropolitan Police since early 2020 to provide whatever information it needs for its investigations. "This has included wide-ranging requests for large volumes of data, all of which we have agreed to. This is in addition to disclosing almost 500,000 documents to the Horizon IT Inquiry. “We will continue to co-operate with the Metropolitan Police as they undertake their investigations."Football clubs ‘alarmed’ by lack of consultation on regulator – Karren BradyAnalysis included 230 studies—a mix of randomized, prospective, and database research SUNNYVALE, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:ISRG) The peer-reviewed Annals of Surgery published a meta-analysis of 30-day surgical outcomes across seven oncological surgical procedures , comparing robotic, laparoscopic, and open surgical approaches. The study covered a 12-year timeframe and analyzed 230 studies from 22 countries: 34 randomized controlled trials, 74 prospective studies, and 122 database reviews. Each surgical approach represented more than a million procedures. The meta-analysis, conducted by scientists from Intuitive and Massachusetts General Hospital, demonstrated multiple benefits for robotic surgery using Intuitive’s da Vinci system as compared to laparoscopy and open surgery. “Robotic surgery with da Vinci showed fewer conversions, less blood loss, fewer blood transfusions, fewer readmissions and reoperations, and a shorter length of stay after 30 days,” said Intuitive Executive Vice President and Chief Medical Officer Myriam Curet, MD. “The editors at the Annals of Surgery thoroughly scrutinized and peer-reviewed this study prior to acceptance,” said Curet. “The quality of scientific data we are seeing after decades of robotic surgery underscores the value that the da Vinci robotic approach continues to have for improved surgical care.” Notable study results included: Da Vinci robotic cases were 56 percent less likely to convert to open surgery versus laparoscopy. Da Vinci robotic cases saw less blood loss versus open, comparable blood loss with laparoscopy. Da Vinci robotic cases were 21 percent less likely to require blood transfusions versus laparoscopy and 75 percent versus open. Da Vinci cases were 10 percent less likely to experience 30-day postop complications versus laparoscopy; 44 percent versus open. Da Vinci cases saw a half-day savings in hospital stay compared to laparoscopy and 1.9 days compared to open. Operative time for da Vinci cases was 17.7 minutes longer than laparoscopy and 40.9 minutes longer than open. “The data presented in our study describes the value of robotics in both the controlled clinical setting of randomized controlled trials and in the ‘real-clinical-world’ of population-based studies,” said Rocco Ricciardi, MD, MPH, lead study author and chief of colon and rectal surgery at the Massachusetts General Hospital. “Ultimately, demonstrating population-based gains with robotics allows us to determine value of robotic procedures for the average person who might need surgery.” Traditional minimally invasive surgery offers many benefits but presents several technical limitations—notably lower quality vision and depth perception, camera instability, limited range of motion and dexterity due to the straight and rigid hand-held instruments, and it can take a severe physical toll on the surgeon. Intuitive technology introduced in the da Vinci surgical system has helped surgeons overcome many of those technological limitations via advanced 3DHD vision, wristed instrumentation, and greater precision, especially in deep, limited, or narrow areas of the body such as the chest, abdomen, and pelvis. There have been numerous studies comparing perioperative outcomes between robotic, laparoscopic, and open surgery but they have focused on individual procedures, which result in procedure-specific evaluations. Intuitive’s study in the Annals of Surgery looked at randomized controlled trials, prospective cohort, and database studies published within the last 12 years, and it shows multiple benefits for robotic surgery using the da Vinci system compared to laparoscopic and open surgery, which may be useful to decision makers who are considering the use of robotics in a multi-specialty setting. The study scope focused on 30-day outcomes specific to oncology procedures that often require deep and narrow surgical access. It did not review oncologic outcomes. About Intuitive Intuitive (NASDAQ:ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most. About da Vinci Surgical Systems There are several models of the da Vinci Surgical System. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body. For more information, please visit the company’s website at www.intuitive.com . Important Safety Information Serious complications may occur in any surgery, including da Vinci surgery, up to and including death. Serious risks include, but are not limited to, injury to tissues and organs and conversion to other surgical techniques which could result in a longer operative time and/or increased complications. For summary of the risks associated with surgery refer to www.intuitive.com/safety. For product intended use and/or indications for use, risks, cautions, and warnings and full prescribing information, refer to the associated user manual(s) or visit https://manuals.intuitivesurgical.com/market. Individual outcomes may depend on a number of factors—including but not limited to—patient characteristics, disease characteristics, and/or surgeon experience. Contact Information Peper Long, Intuitive 202-997-7373 peper.long@intusurg.com
Old friends Conners and Henderson reunite at Grant Thornton InvitationalHegseth faces senators' concerns not only about his behavior but also his views on women in combat
Proceeds to be used primarily to acquire bitcoin and repurchase existing convertible notes due 2026 Fort Lauderdale, FL, Dec. 04, 2024 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) (“MARA” or the “Company”), a global leader in leveraging digital asset compute to support the energy transformation, today announced the closing on December 4, 2024 of its offering of 0.00% convertible senior notes due 2031 (the “notes”). The aggregate principal amount of the notes sold in the offering was $850 million. MARA also granted the initial purchasers an option to purchase an additional $150 million aggregate principal amount of the notes within a 13-day period beginning on, and including, the date on which the notes were first issued. The notes were sold in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The net proceeds from the sale of the notes were approximately $835.1 million, after deducting the initial purchasers’ discounts and commissions but before estimated offering expenses payable by MARA. MARA expects to use approximately $48 million of the net proceeds from the sale of the notes to repurchase approximately $51 million in aggregate principal amount of its existing convertible notes due 2026 (the “existing 2026 convertible notes”) in privately negotiated transactions with the remainder of the net proceeds to be used to acquire additional bitcoin and for general corporate purposes, which may include working capital, strategic acquisitions, expansion of existing assets, and repayment of additional debt and other outstanding obligations. The notes are unsecured, senior obligations of MARA. The notes will not bear regular interest and the principal amount of the notes will not accrete. MARA may pay special interest, if any, at its election as the sole remedy for failure to comply with its reporting obligations and under certain other circumstances, each pursuant to the indenture. Special interest, if any, on the notes will be payable semi-annually in arrears on June 1 and December 1 of each year, beginning on June 1, 2025 (if and to the extent that special interest is then payable on the notes). The notes will mature on June 1, 2031, unless earlier repurchased, redeemed or converted in accordance with their terms. Subject to certain conditions, on or after June 5, 2029, MARA may redeem for cash all or any portion of the notes at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid special interest, if any, to, but excluding, the redemption date, if the last reported sale price of MARA’s common stock has been at least 130% of the conversion price then in effect for a specified period of time ending on, and including, the trading day immediately before the date MARA provides the notice of redemption. If MARA redeems fewer than all the outstanding notes, at least $75 million aggregate principal amount of notes must be outstanding and not subject to redemption as of the relevant redemption notice date. Holders of notes may require MARA to repurchase for cash all or any portion of their notes on June 4, 2027 and on June 4, 2029 or upon the occurrence of certain events that constitute a fundamental change under the indenture governing the notes at a repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid special interest, if any, to, but excluding, the date of repurchase. In connection with certain corporate events or if MARA calls any note for redemption, it will, under certain circumstances, be required to increase the conversion rate for holders who elect to convert their notes in connection with such corporate event or notice of redemption. The notes are convertible into cash, shares of MARA’s common stock, or a combination of cash and shares of MARA’s common stock, at MARA’s election. Prior to March 1, 2031, the notes are convertible only upon the occurrence of certain events and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The conversion rate for the notes is initially 28.9159 shares of MARA’s common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $34.5830 per share. The initial conversion price of the notes represents a premium of approximately 40.0% over the U.S. composite volume weighted average price of MARA’s common stock from 2:00 p.m. through 4:00 p.m. Eastern Daylight Time on Monday, December 2, 2024, which was $24.7022. The conversion rate is subject to adjustment upon the occurrence of certain events. In connection with any repurchase of the existing 2026 convertible notes, MARA expects that holders of the existing 2026 convertible notes who agree to have their notes repurchased and who have hedged their equity price risk with respect to such notes (the “hedged holders”) will unwind all or part of their hedge positions by buying MARA’s common stock and/or entering into or unwinding various derivative transactions with respect to MARA’s common stock. The amount of MARA’s common stock to be purchased by the hedged holders or in connection with such derivative transactions may be substantial in relation to the historic average daily trading volume of MARA’s common stock. This activity by the hedged holders could increase (or reduce the size of any decrease in) the market price of MARA’s common stock, including concurrently with the pricing of the notes, resulting in a higher effective conversion price of the notes. MARA cannot predict the magnitude of such market activity or the overall effect it will have on the price of the notes or MARA’s common stock. The notes were sold to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act. The offer and sale of the notes and the shares of MARA’s common stock issuable upon conversion of the notes, if any, have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction, and the notes and any such shares may not be offered or sold in the United States absent registration or an applicable exemption from such registration requirements. The offering of the notes was made only by means of a private offering memorandum. This press release shall not constitute an offer to sell, or a solicitation of an offer to buy, the notes, nor shall there be any sale of the notes in any state or jurisdiction in which such offer, solicitation or sale would be unlawful under the securities laws of any such state or jurisdiction. Nothing in this press release shall be deemed an offer to purchase MARA’s existing 2026 convertible notes. About MARA MARA (NASDAQ:MARA) is a global leader in digital asset compute that develops and deploys innovative technologies to build a more sustainable and inclusive future. MARA secures the world’s preeminent blockchain ledger and supports the energy transformation by converting clean, stranded, or otherwise underutilized energy into economic value. Forward-Looking Statements Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to MARA’s use of the net proceeds of the offering. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the factors discussed in the “Risk Factors” section of MARA’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 28, 2024, as amended on May 24, 2024, the “Risk Factors” section of MARA’s Quarterly Report on Form 10-Q filed with the SEC on August 1, 2024, the “Risk Factors” section of MARA’s Quarterly Report on Form 10-Q filed with the SEC on November 12, 2024 and the risks described in other filings that MARA may make from time to time with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and MARA specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise, except to the extent required by applicable law. MARA Company Contact: Telephone: 800-804-1690 Email: ir@mara.com
Argan: Fiscal Q3 Earnings Snapshot
Dover Corp. stock outperforms competitors despite losses on the dayEmboldened by the view from the top of the NFC North, the Detroit Lions are out to eliminate nightmare holiday gatherings when the Chicago Bears come to town Thursday for a lunchtime division duel. The Lions (10-1) are streaking one direction, the Bears (4-7) the other in the first matchup of the season between teams on opposite ends of the division. Riding a nine-game winning streak, their longest since a 10-game streak during their first season in Detroit in 1934, the Lions are burdened by losses in their traditional Thanksgiving Day game the past seven seasons. Three of the defeats are courtesy of Chicago. The Bears and Lions get together for the 20th time on Thanksgiving -- the Bears have 11 wins -- this week in the first of two meetings between the teams in a 25-day span. Detroit goes to Soldier Field on Dec. 22. "I think there's two things," Campbell said of the Thanksgiving losing streak. "Number one -- Get a W. And it's a division win that's why this huge. Number two is because the players are going to get a couple of days off. So, they have family, friends in, it'd be nice to feel good about it when you're with everybody because it's just not real fun. It's not real fun to be around." Detroit (10-1) owns the best record in the NFC but the Lions aren't even assured of a division title. Minnesota sits one game behind them and Green Bay is two games back. The Bears (4-7) sit in last place and would likely need to run the table to have any chance of making the playoffs. The Lions have been dominant in all phases and haven't allowed a touchdown in the past 10 consecutive quarters. Detroit's offense ranks first in points per game (32.7) and second in total yardage (394.3) The Lions defense has not given up a touchdown in the last 10 quarters. Rookie placekicker Jake Bates has made all 16 of his field goal attempts, including four from 50-plus yards over the past three games. Chicago shows up in a foul mood. The Bears are saddled with a five-game losing streak and Chicago's defense has been destroyed for nearly 2,000 total yards in the last four games. The Bears failed to reach the 20-point mark four times in five outings since they last won a game. In their latest defeat, rookie quarterback Caleb Williams and the offense perked up but they lost to Minnesota in overtime, 30-27. "We have to play complementary football for us to be able to win these games," coach Matt Eberflus said. "The games we have won, we have done that. The games we have been close we've missed the mark a little bit. Over the course of the year, it's been one side or the other, this side or that side. In this league you have to be good on all sides to win. That's what we are searching for." Williams threw for 340 yards and two touchdowns without an interception. The wide receiver trio of DJ Moore, Keenan Allen and Romeo Odunze combined for 21 receptions and two touchdowns while tight end Cole Kmet caught seven passes. "What I've been impressed with is just how he has grown," Campbell said. "He has grown every game but these last two I really feel like he's taken off and what they're doing with him has been really good for him and he just looks very composed. He doesn't get frazzled, plays pretty fast, and he's an accurate passer, big arm, and he's got some guys that can get open for him." Detroit's banged-up secondary could be susceptible against the Bears' veteran receivers in their bid to pull off an upset on Thursday. The Lions put two defensive backs on injured reserve in the past week and top cornerback Carlton Davis isn't expected to play due to knee and thumb injuries. Detroit offensive tackle Taylor Decker (knee) and top returner Kalif Raymond (foot) are also expected to miss the game, though Campbell expressed optimism that running back David Montgomery (shoulder), formerly of the Bears, would play. Bears safety Elijah Hicks was listed as a DNP for Tuesday's walkthrough. --Field Level Media